Illinois Tool Works Inc. vs 22nd Century Group Inc — how do they compare? Illinois Tool Works Inc. trades at $271.88 (market cap $78.17B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Illinois Tool Works Inc. is far larger — about 52463.1× 22nd Century Group Inc's market cap, and Illinois Tool Works Inc. pays a 2.37% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| ITW | XXII | |
|---|---|---|
Market Cap | $78.17B | $1.49M |
Sector | Industrials | Technology |
52-Week High | $299.60 | $1.07K |
52-Week Low | $241.07 | $3.90 |
Enterprise Value | $86.49B | -$6.74M |
Dividend Yield | 2.37% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $4.32, down 0.23% with bearish technical signals. The company shows negative profitability with -65.76% net income margin and -130.19% ROE, though valuation ratios appear low with P/S of 0.03. Recent corporate actions include a 20:1 reverse stock split in June 2026. The company is expanding VLN product distribution in key markets including California and New York, supported by positive FDA regulatory developments.
While analyst consensus is 75% buy-rated, fundamental challenges persist with consistent revenue declines and negative cash flow from operations. Investment opportunity lies in successful VLN brand expansion and regulatory approvals, but risks include ongoing losses, competitive tobacco market pressures, and execution uncertainty in scaling reduced-nicotine products.
Trailing returns across standard periods
Latest headlines on both assets
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →